These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 10897801
1. Long-term portocaval shunt and changes in rat brain amine systems. Fogel WA, Andrzejewski W, Sasiak K. Neurobiology (Bp); 1999; 7(4):413-20. PubMed ID: 10897801 [Abstract] [Full Text] [Related]
2. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, Butterworth RF. J Hepatol; 2004 May; 40(5):742-8. PubMed ID: 15094220 [Abstract] [Full Text] [Related]
3. The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts. Fogel WA, Andrzejewski W, Sasiak K, Maslinski C. Inflamm Res; 2000 Apr; 49 Suppl 1():S45-6. PubMed ID: 10864416 [No Abstract] [Full Text] [Related]
4. Cerebral and gastric histamine system is altered after portocaval shunt. Fogel WA, Michelsen KA, Panula P, Sasiak K, Andrzejewski W. J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):657-70. PubMed ID: 11787765 [Abstract] [Full Text] [Related]
6. [Changes in brain monoamine neurotransmitter in iron deficiency nonanemic rats]. Hu R, Wei M, Ding X. Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):351-3. PubMed ID: 9388911 [Abstract] [Full Text] [Related]
7. Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters. Adjou KT, Dilda P, Aumond P, Gueddari S, Deslys JP, Dormont D, Seman M. Neurochem Int; 2008 Jun; 52(8):1416-21. PubMed ID: 18442871 [Abstract] [Full Text] [Related]
9. [Experimental studies of the pathomechanism of portal encephalopathy. I. Changes in monoamine oxidase (MAO) activity in the cerebral cortex and cerebellum of rats after portacaval shunt]. Rokicki W, Rokicki M, Kamiński K, Peciak B, Gebska E. Neuropatol Pol; 1989 Jun; 27(2):199-207. PubMed ID: 2626178 [Abstract] [Full Text] [Related]
10. Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice. Fornai F, Giorgi FS, Gesi M, Chen K, Alessrì MG, Shih JC. Synapse; 2001 Mar 01; 39(3):213-21. PubMed ID: 11169770 [Abstract] [Full Text] [Related]
11. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase]. Iagodina OV. Zh Evol Biokhim Fiziol; 2008 Mar 01; 44(6):570-6. PubMed ID: 19198157 [Abstract] [Full Text] [Related]
12. Long-term effects of portacaval anastomosis on the 5-hydroxytryptamine, histamine, and catecholamine neurotransmitter systems in rat brain. Lozeva V, MacDonald E, Belcheva A, Hippeläinen M, Kosunen H, Tuomisto L. J Neurochem; 1998 Oct 01; 71(4):1450-6. PubMed ID: 9751177 [Abstract] [Full Text] [Related]
13. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Guang HM, Du GH. Acta Pharmacol Sin; 2006 Jun 01; 27(6):760-6. PubMed ID: 16723097 [Abstract] [Full Text] [Related]
14. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). Anichtchik O, Sallinen V, Peitsaro N, Panula P. J Comp Neurol; 2006 Oct 10; 498(5):593-610. PubMed ID: 16917825 [Abstract] [Full Text] [Related]
15. Effect of pargyline on brain N-tele-methylhistamine in portocaval-shunted rats: relation to amine neurotransmitters. Fogel WA, Tuomisto L, Sasiak K, Rokicki W, Rokicki M, MacDonald E, Maslinski C. J Neurochem; 1994 Feb 10; 62(2):615-20. PubMed ID: 7905026 [Abstract] [Full Text] [Related]
16. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions. Tekes K, Magyar K. Neurobiology (Bp); 2000 Feb 10; 8(3-4):257-64. PubMed ID: 11225517 [Abstract] [Full Text] [Related]
17. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats. Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T. Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506 [Abstract] [Full Text] [Related]
18. Chronic intraperitoneal injection of interferon-alpha reduces serotonin levels in various regions of rat brain, but does not change levels of serotonin transporter mRNA, nitrite or nitrate. Sato T, Suzuki E, Yokoyama M, Semba J, Watanabe S, Miyaoka H. Psychiatry Clin Neurosci; 2006 Aug 27; 60(4):499-506. PubMed ID: 16884454 [Abstract] [Full Text] [Related]
19. Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Dhanda S, Sandhir R. Behav Brain Res; 2015 Jun 01; 286():222-35. PubMed ID: 25639545 [Abstract] [Full Text] [Related]
20. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. Gal S, Zheng H, Fridkin M, Youdim MB. J Neurochem; 2005 Oct 01; 95(1):79-88. PubMed ID: 16181414 [Abstract] [Full Text] [Related] Page: [Next] [New Search]